Open AccessP760: PATTERNS OF HYPOMETHYLATING AGENT FAILURE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
Author(s) -
Chien K.,
Kim K.,
Li Z.,
Kanagal Shamanna R.,
Ong F.,
Montalban Bravo G.,
Kadia T.,
Jabbour E.,
Pemmaraju N.,
Hammond D.,
Short N.,
Ravandi F.,
Alvarado Y.,
Pierce S.,
Dong X. Q.,
Kantarjian H.,
GarciaManero G.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845924.02295.6c
Subject(s) - decitabine , medicine , azacitidine , myelodysplastic syndromes , hypomethylating agent , international prognostic scoring system , oncology , myeloid leukemia , bone marrow , gene , dna methylation , gene expression , biochemistry , chemistry